Abstract:Abstract Background The growth or regeneration of new blood vessels is critical for physiological angiogenesis and for tissue repair in response to injury, such as myocardial infarction. However, the mechanisms underlying the angiogenic processes and, specifically, the regulation of neo-vascularization by microRNAs are not well understood. Purpose To study the potential beneficial role of miRNA-146a in vessel regeneration after myocardial infarction. Methods Mice were subjected to myocardial infarction or hind limb ischemia and vascular development was followed in zebra fish. microRNA-146a was blocked or overexpressed in endothelial cells in vitro or in mice or zebra fish in vivo. Furthermore, Blood samples from patients with ST-elevation myocardial infarction (STEMI) were studied for miR-146a expression. Results MicroRNA-146a was upregulated in the ischemic hind limb following ligation of the femoral artery and in the ischemic myocardium in male C57BL/6 mice following ligation of the left anterior descending (LAD) artery, as well as in patients with STEMI. In vitro, overexpression of microRNA-146a significantly attenuated endothelial cell proliferation and migration, abolished endothelial capillary network formation, and inhibited cell sprouting from endothelial spheroids. In contrast, microRNA-146a silencing had opposite effects. Mechanistically, Nox4, Notch1, and nRas were identified by in silico prediction and microarray mRNA expression analysis, and validated as direct targets and effector molecules of microRNA-146a in endothelial cells according to mRNA and protein expression profiles, as well as luciferase gene reporter assays and respective rescue experiments. In zebrafish, overexpression of microRNA-146a inhibited the development of the trunk vasculature. Blocking the upregulation of endothelial microRNA-146a in mice,using specific inhibitors, resulted in significantly enhanced 1 angiogenesis and revascularization both in an ischemic hind limb model and in the infarcted myocardium. This was accompanied by a significantly reduced myocardial infarct size and preserved cardiac function post MI. Conclusions Our findings identify microRNA-146a as a critical regulator of angiogenesis and vascular regeneration. Inhibition of microRNA-146a may represent an attractive strategy for the angiogenic therapy of ischemic tissue diseases. Funding Acknowledgement Type of funding source: None

512-P: Single-Cell RNA-Sequencing Identifies Novel Molecular Targets of Endothelial MicroRNA-200b in the Diabetic Ischemic Wound

171-OR: Tissue Nanotransfection–Based Endothelial-Targeted Epigenetic Gene Editing In Vivo to Rescue Diabetic Ischemic Wounds

Abstract 11333: Muscle Specific MicroRNA-499-5p Impairs Angiogenesis in Ischemic Hindlimb of Diabetic Micehindlimb of Diabetic Mice

Abstract P2065: Ischemic Injury Aggravated Muscle-specific Mir-499-5p-impaired Angiogenic Property Of Endothelial Cell In Hindlimb Of Diabetic Db/db Mice: Role Of Small Extracellular Vesicles

510-P: Tissue Nanotransfection–Based Endothelial-Targeted Epigenetic Gene Editing In Vivo to Rescue Diabetic Ischemic Wounds

miR-200b-3p accelerates diabetic wound healing through anti-inflammatory and pro-angiogenic effects

MicroRNA-409-3p/BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice

Angiogenesis in diabetic mouse model with critical limb ischemia; cell and gene therapy

MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia

The Role of MicroRNA-206 in the Regulation of Diabetic Wound Healing via Hypoxia-Inducible Factor 1-Alpha

Microarray meta-analysis reveals IL6 and p38β/MAPK11 as potential targets of hsa-miR-124 in endothelial progenitor cells: Implications for stent re-endothelization in diabetic patients

MicroRNA-200a Improves Diabetic Endothelial Dysfunction by Targeting KEAP1/NRF2.

Mirna-200C-3p Promotes Endothelial to Mesenchymal Transition and Neointimal Hyperplasia in Artery Bypass Grafts.

MicroRNA Mir-27B Rescues Bone Marrow–Derived Angiogenic Cell Function and Accelerates Wound Healing in Type 2 Diabetes Mellitus

Microrna-93 Controls Perfusion Recovery After Hindlimb Ischemia By Modulating Expression Of Multiple Genes In The Cell Cycle Pathway

Abstract WP306: Endothelial CD200 Signaling Protects Brain Against Ischemic Damage

E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model

Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells

Inhibiting Anti-angiogenic VEGF165b Activates a Novel miR-17-20a-Calcipressin-3 Pathway that Revascularizes Ischemic Muscle in Peripheral Artery Disease

Endothelial S1pr2 regulates post-ischemic angiogenesis via AKT/eNOS signaling pathway

MicroRNA-146a regulates angiogenesis and functional regeneration after myocardial infarction